Literature DB >> 7576309

Brief overview of control of genetic expression by antisense oligonucleotides and in vivo applications. Prospects for neurobiology.

G Zon1.   

Abstract

Over the past several years, the use of synthetic oligonucleotides and functional analogs thereof as a possibly general means of controlling genetic expression has received widespread attention. Following a brief overview of some of the basic principles and strategies for this approach, attention is focused here on summarizing some recent reports of in vitro and, in particular, in vivo investigations in various animal models using phosphorothioate analogs of 2'-deoxyoligonucleotides. In view of these findings, which include studies related to neurobiology, this field should find significant utility in applications of the antisense method for controlling genetic expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7576309     DOI: 10.1007/BF02740677

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  49 in total

1.  Synthesis of phosphorothioate analogues of oligodeoxyribonucleotides and their antiviral activity against human immunodeficiency virus (HIV).

Authors:  M Matsukura; G Zon; K Shinozuka; C A Stein; H Mitsuya; J S Cohen; S Broder
Journal:  Gene       Date:  1988-12-10       Impact factor: 3.688

2.  The involvement of "tumor suppressor" p53 in normal and chronic myelogenous leukemia hemopoiesis.

Authors:  S Bi; F Lanza; J M Goldman
Journal:  Cancer Res       Date:  1994-01-15       Impact factor: 12.701

3.  The abnormal p53 proteins expressed in CML cell lines are non-functional.

Authors:  S Bi; F Lanza; J M Goldman
Journal:  Leukemia       Date:  1993-11       Impact factor: 11.528

4.  Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury.

Authors:  Y Shi; A Fard; A Galeo; H G Hutchinson; P Vermani; G R Dodge; D J Hall; F Shaheen; A Zalewski
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690

5.  The mitogenic response of T cells to interleukin-2 requires Raf-1.

Authors:  D Riedel; U Brennscheidt; M Kiehntopf; M Brach; F Herrmann
Journal:  Eur J Immunol       Date:  1993-12       Impact factor: 5.532

6.  Effect of over-expression of bacterial ribonuclease H on the utility of antisense MYC oligodeoxynucleotides in the monocytic leukemia cell line U937.

Authors:  A Rosolen; E Kyle; C Chavany; R Bergan; E T Kalman; R Crouch; L Neckers
Journal:  Biochimie       Date:  1993       Impact factor: 4.079

7.  Cloning and antisense oligodeoxynucleotide inhibition of a human homolog of cdc2 required in hematopoiesis.

Authors:  Y Lapidot-Lifson; D Patinkin; C A Prody; G Ehrlich; S Seidman; R Ben-Aziz; F Benseler; F Eckstein; H Zakut; H Soreq
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

8.  Antisense oligonucleotides to interleukin-4 regulate IgE and IgG2a production by spleen cells from Nippostrongylus brasiliensis-infected rats.

Authors:  N Benbernou; P Matsiota-Bernard; M Guenounou
Journal:  Eur J Immunol       Date:  1993-03       Impact factor: 5.532

9.  An antisense oligodeoxynucleotide that depletes RI alpha subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells.

Authors:  H Yokozaki; A Budillon; G Tortora; S Meissner; S L Beaucage; K Miki; Y S Cho-Chung
Journal:  Cancer Res       Date:  1993-02-15       Impact factor: 12.701

10.  Antisense attenuation of Wnt-1 and Wnt-3a expression in whole embryo culture reveals roles for these genes in craniofacial, spinal cord, and cardiac morphogenesis.

Authors:  K Augustine; E T Liu; T W Sadler
Journal:  Dev Genet       Date:  1993
View more
  1 in total

Review 1.  Strategy for designing specific antisense oligonucleotide sequences.

Authors:  M Mitsuhashi
Journal:  J Gastroenterol       Date:  1997-04       Impact factor: 7.527

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.